Found: 6
Select item for more details and to access through your institution.
Targeting cellular metabolism using rapamycin and/or doxycycline enhances anti-tumour effects in human glioma cells.
- Published in:
- Cancer Cell International, 2018, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12935-018-0710-0
- By:
- Publication type:
- Article
Rapamycin (mTORC1 inhibitor) reduces the production of lactate and 2- hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cells.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2017, v. 36, p. 1, doi. 10.1186/s13046-017-0544-y
- By:
- Publication type:
- Article
Glutaminases as a Novel Target for SDHB-Associated Pheochromocytomas/Paragangliomas.
- Published in:
- Cancers, 2020, v. 12, n. 3, p. 599, doi. 10.3390/cancers12030599
- By:
- Publication type:
- Article
Inhibition of Metabolic Shift can Decrease Therapy Resistance in Human High-Grade Glioma Cells.
- Published in:
- Pathology & Oncology Research, 2020, v. 26, n. 1, p. 23, doi. 10.1007/s12253-019-00677-2
- By:
- Publication type:
- Article
The Effects of Different mTOR Inhibitors in EGFR Inhibitor Resistant Colon Carcinoma Cells.
- Published in:
- Pathology & Oncology Research, 2019, v. 25, n. 4, p. 1379, doi. 10.1007/s12253-018-0434-4
- By:
- Publication type:
- Article
GABA, glutamine, glutamate oxidation and succinic semialdehyde dehydrogenase expression in human gliomas.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2018, v. 37, n. 1, p. N.PAG, doi. 10.1186/s13046-018-0946-5
- By:
- Publication type:
- Article